Inovio Pharmaceuticals
INO
INO
183 hedge funds and large institutions have $197M invested in Inovio Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
183
Holders Change
+1
Holders Change %
+0.55%
% of All Funds
2.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
57
Reduced
49
Closed
25
Calls
$2.24M
Puts
$1.89M
Net Calls
+$352K
Net Calls Change
+$498K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$49.1M |
| 2 |
2
Millennium Management
New York
|
$6.73M |
| 3 |
3
BlackRock
New York
|
$36.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$26.6M |
| 5 |
5
D.E. Shaw & Co
New York
|
$13.2M |
Top Sellers
| 1 |
1
Two Sigma Investments
New York
|
$659K |
| 2 |
2
Two Sigma Advisers
New York
|
$2.05M |
| 3 |
3
VOYA Investment Management
Atlanta,
Georgia
|
$145K |
| 4 |
4
Citigroup
New York
|
$1.84M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$314K |
